vimarsana.com

TIB Molbiol excels in ultra-rapid assay development for emerging infectious disease, strongly demonstrated during the COVID-19 pandemicThe acquisition enables Roche to further expand the portfolio of currently

Related Keywords

United States ,Berlin ,Germany ,America ,Nathalie Meetz ,Karl Mahler ,Sabine Borngr ,Gerard Tobin ,Bruno Eschli ,Birgit Masjost ,Sileia Urech ,Thomas Schinecker ,Loren Kalm ,Karsten Kleine ,Roche Lightcycler ,Molbiol Group ,Roche Group Media Relations ,Hoffmann ,Oche ,Ompletes ,Purchase ,Agreement ,Song ,Term ,Partner ,Olbiol ,Xpand ,Pest ,Portfolio ,Flight ,Against ,Nfectious ,Diseases ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.